These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7371699)

  • 1. Acute and long-term effects of labetalol on systemic and pulmonary haemodynamics in hypertensive patients.
    Svendsen TL; Rasmussen S; Hartling OJ; Nielsen PE; Trap-Jensen J
    Eur J Clin Pharmacol; 1980 Jan; 17(1):5-11. PubMed ID: 7371699
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic study of a new injectable anti-hypertensive: labetalol].
    Clementy J; Dallocchio M
    Nouv Presse Med; 1978 Dec; 7(43):3934. PubMed ID: 733550
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute hemodynamic effects of labetalol in severe hypertension.
    Omvik P; Lund-Johansen P
    J Cardiovasc Pharmacol; 1982; 4(6):915-20. PubMed ID: 6185782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of labetalol on systemic and pulmonary haemodynamics at rest and during exercise in hypertensive patients.
    Fagard R; Amery A; Reybrouck T; Lijnen P; Billiet L
    Clin Sci Mol Med Suppl; 1978 Dec; 4():279s-281s. PubMed ID: 282068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic effects of long-term oral labetalol.
    Edwards RC; Raftery EB
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of the systemic pulmonary circulation to labetalol at rest and during exercise.
    Fagard R; Lijnen P; Amery A
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):13S-17S. PubMed ID: 7046773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hemodynamic effects of an alpha- and beta-receptor blocking agent (AH 5158) on the systemic and pulmonary circulation at rest and during exercise in hypertensive patients.
    Koch G
    Am Heart J; 1977 May; 93(5):585-91. PubMed ID: 851058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
    Koch G
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension.
    Ronne-Rasmussen JO; Andersen GS; Jensen NB; Andersson E
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):805-8. PubMed ID: 990157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrophysiologic properties of intravenous labetalol in normotensive and hypertensive patients].
    Clémenty J; Dallocchio M; Bricaud H
    Arch Mal Coeur Vaiss; 1981 Jan; 74(1):65-71. PubMed ID: 6781440
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol.
    Koch G
    Br Heart J; 1979 Feb; 41(2):192-8. PubMed ID: 106867
    [No Abstract]   [Full Text] [Related]  

  • 13. Immediate effects of labetalol on central, splanchnic-hepatic, and forearm haemodynamics during pleasant emotional stress in hypertensive patients.
    Trap-Jensen J; Clausen JP; Hartling OJ; Svendsen TL; Krogsgaard AR
    Postgrad Med J; 1980; 56 Suppl 2():37-42. PubMed ID: 7433341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of acute and long-term treatment with labetalol.
    Lysbo Svendsen T; Rasmussen S; Nielsen PE; Hartling O; Trap-Jensen J
    Acta Med Scand Suppl; 1979; 625():49-53. PubMed ID: 285575
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension.
    Bahlmann J; Brod J; Hubrich W; Cachovan M; Pretschner P
    Br J Clin Pharmacol; 1979; 8(Suppl 2):113S-117S. PubMed ID: 526390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of intravenous labetalol in essential hypertension.
    Dunn FG; Oigman W; Messerli FH; Dreslinski GR; Reisin E; Frohlich ED
    Clin Pharmacol Ther; 1983 Feb; 33(2):139-43. PubMed ID: 6822026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent.
    Joekes AM; Thompson FD
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):789-93. PubMed ID: 990156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of onset of hypotensive response with oral labetalol [proceedings].
    Breckenridge AM; Macnee CM; Orme NL; Richards DA; Sterlin MJ
    Br J Clin Pharmacol; 1977 Jun; 4(3):388P. PubMed ID: 901712
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of intravenous labetalol on hemodynamics and myocardial metabolism in coronary insufficiency].
    Lardoux H; Ourbak P; Pornin M; Duong TC; Chouty F; Maurice P
    Therapie; 1983; 38(2):149-54. PubMed ID: 6636022
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.
    Mehta J; Feldman RL; Marx JD; Kelly GA
    Am J Med; 1983 Oct; 75(4A):32-9. PubMed ID: 6638039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.